{"id":60196,"date":"2024-10-18T22:08:01","date_gmt":"2024-10-18T20:08:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/"},"modified":"2024-10-18T22:08:01","modified_gmt":"2024-10-18T20:08:01","slug":"savara-announces-new-employment-inducement-grant","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/","title":{"rendered":"Savara Announces New Employment Inducement Grant"},"content":{"rendered":"
\n

LANGHORNE, Pa.–(BUSINESS WIRE)–Savara Inc.<\/a> (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to four new employees.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nOn October 17, 2024, the Compensation Committee of Savara’s Board of Directors granted the inducement awards to four new employees who recently joined the Company. The inducement awards consist of options to purchase an aggregate of 95,000 shares of the Company\u2019s common stock and restricted stock units (RSUs) covering an aggregate of 95,000 shares of the Company\u2019s common stock. These equity awards were granted under the Savara Inc. 2021 Inducement Equity Incentive Plan pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules as an inducement material to the employees\u2019 acceptance of employment with the Company.\n<\/p>\n

\nThe options have an exercise price of $3.65 per share, the closing trading price of the Company’s common stock on the NASDAQ Global Market on the grant date. Each option has a 10-year term and vests as to 1\/16th<\/sup> of the number of shares subject to the option on each quarterly anniversary of the employee\u2019s first day of employment, subject to the employee\u2019s continued employment on each such vesting date. The RSUs vest in full on the two-year anniversary of the employee\u2019s first day of employment, subject to the employee\u2019s continued employment on such vesting date.\n<\/p>\n

\nAbout Savara<\/b>\n<\/p>\n

\nSavara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim inhalation solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow\u00ae<\/sup> Nebulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization. More information can be found at www.savarapharma.com<\/a>. (X, formerly known as Twitter: @SavaraPharma<\/a>, LinkedIn: www.linkedin.com\/company\/savara-pharmaceuticals\/<\/a>).\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSavara Inc. IR & PR<\/b>
Anne Erickson (anne.erickson@savarapharma.com<\/a>)
\n
(512) 851-1366\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LANGHORNE, Pa.–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to four new employees. On October 17, 2024, the Compensation Committee of Savara’s Board of Directors granted the inducement awards to four new employees who recently joined the Company. The inducement awards … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60196","6":"format-standard","7":"category-industry"},"yoast_head":"\nSavara Announces New Employment Inducement Grant - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Savara Announces New Employment Inducement Grant - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LANGHORNE, Pa.–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to four new employees. On October 17, 2024, the Compensation Committee of Savara’s Board of Directors granted the inducement awards to four new employees who recently joined the Company. The inducement awards ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-18T20:08:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20241018690811\/en\/1383816\/22\/Savara_Logo_%28002%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/savara-announces-new-employment-inducement-grant\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/savara-announces-new-employment-inducement-grant\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Savara Announces New Employment Inducement Grant\",\"datePublished\":\"2024-10-18T20:08:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/savara-announces-new-employment-inducement-grant\\\/\"},\"wordCount\":336,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/savara-announces-new-employment-inducement-grant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241018690811\\\/en\\\/1383816\\\/22\\\/Savara_Logo_%28002%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/savara-announces-new-employment-inducement-grant\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/savara-announces-new-employment-inducement-grant\\\/\",\"name\":\"Savara Announces New Employment Inducement Grant - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/savara-announces-new-employment-inducement-grant\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/savara-announces-new-employment-inducement-grant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241018690811\\\/en\\\/1383816\\\/22\\\/Savara_Logo_%28002%29.jpg\",\"datePublished\":\"2024-10-18T20:08:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/savara-announces-new-employment-inducement-grant\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/savara-announces-new-employment-inducement-grant\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/savara-announces-new-employment-inducement-grant\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241018690811\\\/en\\\/1383816\\\/22\\\/Savara_Logo_%28002%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241018690811\\\/en\\\/1383816\\\/22\\\/Savara_Logo_%28002%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/savara-announces-new-employment-inducement-grant\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Savara Announces New Employment Inducement Grant\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Savara Announces New Employment Inducement Grant - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/","og_locale":"en_US","og_type":"article","og_title":"Savara Announces New Employment Inducement Grant - Pharma Trend","og_description":"LANGHORNE, Pa.–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to four new employees. On October 17, 2024, the Compensation Committee of Savara’s Board of Directors granted the inducement awards to four new employees who recently joined the Company. The inducement awards ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/","og_site_name":"Pharma Trend","article_published_time":"2024-10-18T20:08:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20241018690811\/en\/1383816\/22\/Savara_Logo_%28002%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Savara Announces New Employment Inducement Grant","datePublished":"2024-10-18T20:08:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/"},"wordCount":336,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20241018690811\/en\/1383816\/22\/Savara_Logo_%28002%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/","url":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/","name":"Savara Announces New Employment Inducement Grant - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20241018690811\/en\/1383816\/22\/Savara_Logo_%28002%29.jpg","datePublished":"2024-10-18T20:08:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20241018690811\/en\/1383816\/22\/Savara_Logo_%28002%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20241018690811\/en\/1383816\/22\/Savara_Logo_%28002%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/savara-announces-new-employment-inducement-grant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Savara Announces New Employment Inducement Grant"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60196"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60196\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}